Reuters: Regulatory News: St. Jude wins European approval for transcatheter heart valve

Reuters: Regulatory News Reuters.com is your source for breaking news, business, financial and investing news, including personal finance and stocks. Reuters is the leading global provider of news, financial information and technology solutions to the world's media, financial institutions, businesses and individuals. // via fulltextrssfeed.com

St. Jude wins European approval for transcatheter heart valve Nov 19th 2012, 15:27 Mon Nov 19, 2012 10:27am EST Nov 19 (Reuters) - St. Jude Medical Inc said on Monday that it had received approval from European health regulators to market its transcatheter aortic heart valve. The 23mm (0.9-inch) device, called Portico, was approved for transfemoral delivery. That means the valve is implanted using a catheter that is threaded through the femoral artery, the main artery in the leg, sparing patients the need for open-heart surgery. The product was designed for patients with severe aortic stenosis who are considered to be too high-risk for open-heart surgery. This disease keeps the aortic valve from opening fully, decreasing blood flow from the heart. The St. Jude device would compete in Europe with similar products made by Edwards Lifesciences Corp and Medtronic Inc St. Jude said it intended to initiate a European study of a 25mm version of the valve to support European approval before the end of the year.

You are receiving this email because you subscribed to this feed at blogtrottr.com. If you no longer wish to receive these emails, you can unsubscribe from this feed, or manage all your subscriptions